{"disease":{"id":"orl-cancer","name":"orl cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03896958","title":"The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"SpeciCare","has_results":false},{"nct_id":"NCT06726720","title":"UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04420754","title":"Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"AffyImmune Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05494970","title":"Accompaniment of Patients by Dental Assistants in the Evaluation of Oral Hygiene During and After Radiotherapy Treatment.","phase":"","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Institut Claudius Regaud","has_results":false},{"nct_id":"NCT00707473","title":"Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":31,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03449108","title":"LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06639191","title":"[177Lu]Lu-AKIR001 First-in-human Study","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT03002623","title":"CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}